- $501.48m
- $350.62m
- $627.60m
- 58
- 75
- 10
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 636 | 521 | 607 | 651 | 628 |
Cost of Revenue | |||||
Gross Profit | 314 | 219 | 260 | 276 | 267 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 648 | 977 | 672 | 670 | 715 |
Operating Profit | -11.7 | -456 | -64.8 | -18 | -87.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.14 | -457 | -66.8 | -17.8 | -84.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.7 | -440 | -62.9 | -23.2 | -90.4 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -10.4 | -444 | -62 | -29 | -123 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.8 | -444 | -62 | -29 | -123 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.2 | -3.32 | -1.01 | -0.755 | -1.25 |